| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 6,269 | 6,409 | 6,204 | 6,338 | | Cost of Revenue | 1,758 | 1,780 | 1,918 | 2,140 | | | Gross Profit |
-
| 4,629 | 4,286 | 4,198 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,916 | 3,642 | 3,063 | 3,654 | | Non Recurring |
-
|
-
|
-
| 32 | | Others | 2,647 | 2,049 | 1,345 | 2,381 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (1,062) | (122) | (1,868) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (1,052) | (1,062) | (122) | (1,868) | | Interest Expense | 285 | 288 | 318 | 387 | | Income Before Tax | (1,337) | (1,350) | (440) | (2,256) | | Income Tax Expense | (706) | (504) | (184) | (840) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (631) | (846) | (256) | (1,416) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (631) | (846) | (256) | (1,416) | | Preferred Stock And Other Adjustments | (173) | (258) |
-
|
-
| | | Net Income Applicable To Common Shares | ($804) | ($1,104) | ($256) | ($1,416) |
|
0.26% Nasdaq 
Income Statement
